One study showed that the neuraminidase-1 enzyme in human cells may be important in the SARS-CoV-2 entry into host cells, and so oseltamivir may instead act as a host-targeting agent when used to treat COVID-19 [34]. The gene discussed is NEU1; the disease is COVID-19.